News

Peer Review Publication of 36- and 48-month Canaloplasty Data Demonstrates Sustained Reduction in IOP with iTrack™

Media Release iTrack

5 May, 2022

Nova Eye Medical Launches Next Generation Canaloplasty Device for Glaucoma, iTrack™ Advance

Media Release General iTrack

19 Apr, 2022

iTrack™ Canaloplasty to be Featured at the 2022 ASCRS Annual Meeting

Media Release General iTrack

12 Apr, 2022

Nova Eye, Inc., President Appointed to American Glaucoma Society (AGS) Foundation Advisory Board

Media Release General iTrack

31 Mar, 2022

iTrack™ to be Featured at the 2022 American Glaucoma Society (AGS) Annual Meeting

Media Release iTrack

8 Mar, 2022

One Year Evaluation of Endothelial Cell Density Following iTrack™ to be Spotlighted at ESCRS 2021

Media Release General iTrack

8 Oct, 2021

5-Year Effectiveness and Safety Data for iTrack™ to be Spotlighted at ESCRS 2021

Media Release General iTrack

8 Oct, 2021

Long-Term Effectiveness of iTrack™ MIGS Procedure to be Spotlighted at 2021 Swiss Society of Ophthalmology

Media Release General iTrack

25 Aug, 2021

2RT® Featured at the 2021 Meeting of the Association for Research in Vision and Ophthalmology (ARVO)

Media Release General AlphaRET

3 May, 2021

Nova Eye Medical Announces First Patient Enrolled in “MAGIC” Multi-Center Canaloplasty Trial for Glaucoma

Media Release General iTrack

30 Apr, 2021

24-Month iTrack™ Data Demonstrate Real-World Efficacy of Canaloplasty as Standalone and Combined MIGS Procedure

Media Release General iTrack

20 Apr, 2021

Positive Five-Year Post-LEAD Trial Results for 2RT®

Media Release General AlphaRET

5 Mar, 2021

iTrack™ MIGS Procedure to Feature at the American Glaucoma Society (AGS) 2021 Virtual Meeting

Media Release General iTrack

4 Mar, 2021

Prospective Multi-Center Trial to Compare Efficacy and Safety Outcomes of Ab-Interno Canaloplasty for Glaucoma

Media Release General iTrack

2 Mar, 2021

iTrack™ to Feature at Australian and New Zealand Glaucoma Society (ANZGS) 2021 Meeting

Media Release General iTrack

19 Feb, 2021

iTrack™ Under Assessment for Public Funding via Australian Government’s Medical Benefit Scheme

Media Release General iTrack

18 Feb, 2021

iTrack™ MIGS Procedure Under Assessment for Public Funding via the Australian Government’s Medical Benefit Scheme

Media Release General iTrack

18 Feb, 2021

Prospective Case Series Data for iTrack™ Ab-Interno Canaloplasty at European Glaucoma Society (EGS) 2020

Media Release iTrack

12 Dec, 2020

Clinical Update: 2RT® Improves Retinal Function in Cases of Intermediate AMD

Media Release AlphaRET

16 Nov, 2020

iTrack™ and Molteno3® Glaucoma Technologies to Feature at the AAO 2020 Virtual Meeting

Media Release iTrack Molteno3

13 Nov, 2020

iTrack™ MIGS Device Featured in Instructional Training Course at Sydney Eye Hospital, Australia

Media Release iTrack

3 Nov, 2020

Nova Eye Medical Establishes "AlphaRET" to Fulfil the Commercial Development of 2RT®

Media Release AlphaRET

26 Oct, 2020

iTrack™ Pioneer Mahmoud A. Khaimi, MD Awarded James P. Luton, MD Endowed Chair in Ophthalmology

Media Release iTrack

23 Oct, 2020

Long-Term Efficacy and Safety of iTrack™ MIGS Procedure to be Spotlighted at ESCRS 2020

Media Release iTrack

2 Oct, 2020

Multicenter Study Highlights Surgical Efficiency of the Molteno3® Glaucoma Drainage Device

Media Release Molteno3

5 Aug, 2020

Nova Eye Medical Acquires Molteno3 Glaucoma Drainage Device Portfolio

Media Release Molteno3

6 Jul, 2020

For media enquires please contact:

Kate Hunt
Nova Eye Medical Limited
W +61 404 080 679
khunt@nova-eye.com

This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More